Company

Summit Therapeutics Inc.

Tracked in 3 AFBytes stories. First seen Jun 02, 2026. Last seen Jun 02, 2026.

Recent coverage

insidermonkey.com · Jun 2, 2026 09:37 UTC

Cantor Fitzgerald Maintains Overweight Rating on Summit Therapeutics (SMMT) Amid Mixed Clinical Developments

Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the best short squeeze stocks to invest in. On May 22, Cantor Fitzgerald restated its Overweight rating for S...

business

Read story

finance.yahoo.com · Jun 2, 2026 09:37 UTC

Cantor Fitzgerald Maintains Overweight Rating on Summit Therapeutics (SMMT) Amid Mixed Clinical Developments

Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the best short squeeze stocks to invest in. On May 22, Cantor Fitzgerald restated its Overweight rating for S...

business general

Read story

insidermonkey.com · Jun 2, 2026 04:30 UTC

Summit Therapeutics (SMMT) Sheds 10.4%, This Analyst is Pessimistic

In a market note during the day, Bernstein reaffirmed its underperform rating for Summit Therapeutics Inc.

business

Read story

Summit Therapeutics Inc. · AFBytes

Recent coverage

Cantor Fitzgerald Maintains Overweight Rating on Summit Therapeutics (SMMT) Amid Mixed Clinical Developments

Cantor Fitzgerald Maintains Overweight Rating on Summit Therapeutics (SMMT) Amid Mixed Clinical Developments

Summit Therapeutics (SMMT) Sheds 10.4%, This Analyst is Pessimistic